Shares of BiomX Inc. (NYSEAMERICAN:PHGE – Get Free Report) fell 12.2% on Wednesday . The stock traded as low as $0.50 and last traded at $0.51. 103,655 shares changed hands during trading, a decline of 7% from the average session volume of 110,983 shares. The stock had previously closed at $0.58.
BiomX Stock Performance
The firm has a market capitalization of $9.25 million, a P/E ratio of -0.16 and a beta of 1.31.
About BiomX
BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).
Featured Stories
- Five stocks we like better than BiomX
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- 3 Warren Buffett Stocks to Buy Now
- Williams-Sonoma Stock: Buy It and Never Let It Go
- Best Aerospace Stocks Investing
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for BiomX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BiomX and related companies with MarketBeat.com's FREE daily email newsletter.
